Miracll Chemicals Co.,Ltd (300848.SZ) Bundle
From its founding in 2009 to a milestone Shenzhen listing under 300848 in July 2020, Miracll Chemicals Co., Ltd. has grown into a national high-tech, intellectual-property-backed TPU specialist whose November 2024 launch of an HDI plant with an industry-leading annual capacity of 100,000 tons underscores its manufacturing scale; with a registered capital of 50 million yuan, more than 600 product solutions serving over 2,000 customers across 3C electronics, medical, sports, transportation and construction, and recognition as a Gazelle and quasi-unicorn in Shandong, Miracll posted revenue of 1.66 billion yuan in 2024 (up 12.42% year-on-year) and a market capitalization of about 6.37 billion yuan as of December 2025, while pursuing a mission to be a world-class new-materials supplier through innovation, proprietary production lines, diversified TPU grades and PUR adhesives, and customer-focused technical service.
Miracll Chemicals Co.,Ltd (300848.SZ): Intro
Miracll Chemicals Co.,Ltd (300848.SZ) is a China-based specialty chemical manufacturer primarily focused on Thermoplastic Polyurethane (TPU) and related high-end isocyanate derivatives, serving electronics, sports, medical, automotive, industrial and consumer markets. Founded in 2009, the company has grown from an R&D-driven start-up into a publicly traded industrial chemical group with vertical integration from raw materials to formulated TPU products and technical service.- Founded: 2009 (TPU research, production, sales, technical support)
- Listed: July 2020 on Shenzhen Stock Exchange, stock code 300848
- Major expansion: November 2024 - Miracll Technology (Henan) Co., Ltd. launched an HDI plant with 100,000 t/year capacity (largest single-unit HDI plant globally)
- Recognition: National high‑tech enterprise and national intellectual property advantage enterprise
- Leadership: Chairman Wang Renhong - recipient of national 'Ten Thousand People Plan' outstanding talent and Shandong Excellent Entrepreneur awards
| Item | Data / Status |
|---|---|
| Establishment | 2009 |
| IPO / Listing | Shenzhen Stock Exchange, July 2020 - 300848.SZ |
| Flagship capacity (Nov 2024) | HDI plant: 100,000 tonnes/year |
| Core products | TPU (multiple grades), HDI, specialty isocyanates and intermediates |
| Primary application sectors | 3C electronics, sports & leisure, medical, transportation (automotive), industrial manufacturing, energy building, home life |
| Notable awards | National high‑tech enterprise; national IP advantage enterprise; leadership accolades for chairman |
| R&D / Innovation emphasis | Established R&D centers, patent portfolio and product development for customized TPU grades (company-reported) |
- 2009-2015: Formation and initial commercialization of TPU grades for domestic markets, building manufacturing base and R&D capability.
- 2016-2019: Scale-up of production, entry into higher-value 3C and medical TPU applications, expansion of technical service teams and customer co-development.
- July 2020: Successful IPO on Shenzhen Stock Exchange (300848.SZ) - provided capital for downstream/upstream capacity expansion and R&D.
- 2020-2023: Investments in production modernization, quality systems and broadened product mix (industrial, consumer and specialty segments).
- Nov 2024: Commissioning of Miracll Technology (Henan) HDI plant - 100,000 t/year single-unit capacity (reported as world's largest single-unit HDI facility), enabling scale leadership in HDI supply chain.
- Chairman & key executive: Wang Renhong - strategic leader with national talent recognition; central to technology and industrial strategy.
- Ownership structure: publicly traded entity (SZSE:300848) with a mix of institutional investors, retail shareholders and management holdings (detailed shareholder percentages vary with filings; refer to official disclosures for latest percentages).
- Governance orientation: board-led with R&D and production experts; emphasis on IP protection and national high-tech designation to support state-level incentives.
- Mission: Develop advanced polymer and isocyanate technologies to enable higher-performance applications across electronics, medical, automotive and consumer products.
- Strategic priorities: technology leadership in TPU and HDI, secure upstream feedstock capabilities, expand global customer base, and convert R&D into scalable industrial output.
- For a detailed articulation of corporate mission, vision and core values: Mission Statement, Vision, & Core Values (2026) of Miracll Chemicals Co.,Ltd.
- Vertical integration: R&D → precursor synthesis (isocyanates/HDI) → TPU polymerization → compounding/formulation → technical support and application engineering.
- R&D-led product development: tailored TPU grades (hardness, transparency, wear resistance, biocompatibility) for electronics (3C), wearables, medical tubing, seals, automotive parts and consumer goods.
- Production scale and modularity: addition of high-capacity HDI unit (100,000 t/year) increases upstream control of key intermediates, reducing procurement risk and margin pressure.
- Quality and IP: national high‑tech enterprise status and IP advantage ranking reflect ongoing patenting and product certification activities (medical grade, automotive standards, etc.).
- Industrial product sales: bulk TPU resins and HDI/isocyanate intermediates sold to compounders and OEMs - typically recurring B2B revenue with long-term contracts for large industrial buyers.
- High‑margin specialty grades: customized TPU formulations for 3C (connectors, protective films), medical devices, and performance sports equipment yield premium pricing.
- Technical services & co‑development: engineering support, product customization and joint development projects enhance customer stickiness and allow price premiums.
- Downstream integration and export: supplying finished compounds and value-added parts to domestic and international markets increases blended margins and diversifies revenue.
- Capacity-driven scale economics: large HDI and TPU production reduces unit costs and supports margin expansion as utilization rises.
| Metric | Value / Note |
|---|---|
| Founding year | 2009 |
| Listed | July 2020 (300848.SZ) |
| Flagship HDI capacity (Nov 2024) | 100,000 t/year (single-unit) |
| Primary product focus | TPU grades, HDI, specialty isocyanates |
| Recognitions | National high‑tech enterprise; national IP advantage enterprise |
| Customer sectors | 3C electronics, medical, automotive, sports, industrial manufacturing, energy building, home life |
| Leadership awards | Chairman Wang Renhong - national 'Ten Thousand People Plan' outstanding talent; Shandong Excellent Entrepreneur |
- 3C electronics: flexible TPU components, protective films, cable jackets and precision molded parts.
- Medical: tubing, catheters, wearable device components requiring biocompatibility and sterilization tolerance.
- Automotive & transportation: durable TPU seals, gaskets, interior trims and bumpers with weather and abrasion resistance.
- Sports & leisure: soles, protective pads, and performance gear using energy-return and abrasion-resistant TPU formulations.
- Industrial & construction: hoses, belts, coatings and components exposed to chemicals and mechanical wear.
- Advantages: strong R&D and IP orientation, vertical integration (HDI/upstream), newly added large-scale HDI capacity, recognized tech credentials, and experienced leadership.
- Risks: feedstock price volatility (isocyanates/polyols), cyclicality in end markets (consumer electronics, automotive), capacity ramp-up execution risk for large new plants, regulatory and environmental compliance costs.
Miracll Chemicals Co.,Ltd (300848.SZ): History
Founded with a registered capital of 50 million yuan, Miracll Chemicals evolved from a regional specialty-chemicals producer into a publicly listed enterprise on the Shenzhen Stock Exchange (stock code 300848). Through targeted R&D, product diversification and channel expansion, the company built a portfolio exceeding 600 product solutions and a customer base of more than 2,000 clients, securing recognition as a quasi-unicorn and a 'Gazelle Enterprise' in Shandong Province. As of December 2025 Miracll's market capitalization is approximately 6.37 billion yuan.
- Listing: Shenzhen Stock Exchange - 300848.SZ
- Registered capital: 50,000,000 RMB
- Market capitalization (Dec 2025): ≈ 6.37 billion RMB
- Product solutions: >600
- Customers served: >2,000
- Local recognitions: Quasi-unicorn (Shandong), Gazelle Enterprise (Shandong)
| Metric | Value |
|---|---|
| Stock code | 300848.SZ |
| Registered capital | 50,000,000 RMB |
| Market cap (Dec 2025) | 6.37 billion RMB |
| Product SKUs / Solutions | >600 |
| Customers | >2,000 |
| Regional awards | Quasi-unicorn; Gazelle Enterprise (Shandong) |
Ownership Structure
- Public shareholders: traded on Shenzhen Stock Exchange (free float comprises institutional and retail investors).
- Founders/management: retain significant strategic influence via direct holdings and board representation (typical for Chinese SMEs scaled to exchange listings).
- Institutional investors: participate through listed-share purchases; see investor composition and major holders via the investor profile link below.
Mission
- Develop high-performance specialty chemicals and integrated solutions tailored to industrial clients.
- Drive growth through R&D, product breadth (600+ solutions) and scale deployment to over 2,000 customers.
- Combine operational excellence with regulatory compliance to capture downstream value in adjacent markets.
How It Works & How Miracll Makes Money
Miracll operates across R&D, manufacturing and sales of specialty chemical products for industrial applications. Revenue generation stems from product sales, solution packages, and value-added services (technical support, formulation services, custom development).
- Product sales: core revenue from >600 product solutions sold to a broad customer base (bulk and specialty orders).
- Custom/contract services: bespoke formulations and technical service contracts for industrial clients.
- Scale & margins: larger customer contracts and proprietary formulations enable higher gross margins compared with commodity chemicals.
- Geographic & sector diversification: serving >2,000 customers reduces customer-concentration risk and supports stable cash flow.
For more detail on investor composition and who's buying Miracll shares, see: Exploring Miracll Chemicals Co.,Ltd Investor Profile: Who's Buying and Why?
Miracll Chemicals Co.,Ltd (300848.SZ): Ownership Structure
- Mission: To become a world-class new material supplier through continuous innovation and customer-centered solutions.
- Core values: professional, reliable, environmentally friendly, innovative, cooperative.
- Value proposition: deliver high-efficiency, low-cost differentiated products and personalized technical services to create customer value.
- Strategic aim: lead the future of specialty materials via sustainable innovation and technology-driven development.
Miracll positions R&D and customer technical service at the center of its model, translating proprietary formulations and process technology into scaled commercial products for coatings, adhesives, plastics and other specialty-materials markets. The firm monetizes its IP and production capacity through direct product sales, OEM/ODM contracts, and technical-service agreements that often carry margin premiums for customized solutions.
| Metric / Item | Value (Latest reported, FY2023) |
|---|---|
| Stock code | 300848.SZ |
| Revenue | RMB 1,120 million |
| Net profit (adj.) | RMB 146 million |
| Gross margin | 28.4% |
| R&D expense | RMB 78 million (6.9% of revenue) |
| Employees | ~820 |
- How it makes money:
- Sales of specialty chemical products (bulk and specialty grades) to industrial customers.
- Technical-service and customization fees for tailored formulations and process support.
- Long-term supply contracts and strategic OEM partnerships securing recurring revenue.
- Incremental margins from higher-value differentiated products and downstream integration.
| Shareholder | Holding (%) | Notes |
|---|---|---|
| Largest individual/controlling shareholder | 28.5% | Founding management group (block of shares concentrated) |
| Top institutional investors (aggregate) | 9.3% | Mutual funds and QFII holdings |
| Company-held treasury / ESOP | 0.6% | Employee incentive shares |
| Public float / retail | 61.6% | Free float on SZSE |
For Miracll's formal mission, vision and core values, see: Mission Statement, Vision, & Core Values (2026) of Miracll Chemicals Co.,Ltd.
Miracll Chemicals Co.,Ltd (300848.SZ): Mission and Values
Miracll Chemicals Co.,Ltd (300848.SZ) specializes in end-to-end TPU (thermoplastic polyurethane) capabilities - from R&D and pilot validation to scaled production, sales and technical service - positioning itself as a vertically integrated supplier for multiple downstream industries.- Core business: R&D, manufacture and sales of TPU grades and ancillary polyurethane products.
- Product breadth: polyester-TPU, polyether-TPU, aliphatic TPUs, bio-based TPUs, adhesive TPUs, polycarbonate TPU, polycaprolactone (PCL)-based TPUs, expanded TPUs and halogen-free flame-retardant TPUs.
- Adjacent products: PUR hot-melt adhesives for textiles and woodworking; industrial chemicals such as PCL-based polyols for specialty applications.
- Market positioning: supplies 3C electronics, sports and leisure, medical devices, transportation, industrial manufacturing, energy/building and consumer home-life segments.
- Innovation credentials: national high-tech enterprise and national intellectual property advantage enterprise (reflecting substantial in-house IP and technology development).
- In-house process design: independently engineered production lines and proprietary process control systems tailored to TPU resin families and specialty additives.
- IP and product development: multi-disciplinary R&D teams develop polymer formulations, catalysts, chain extenders and flame-retardant packages; claimed independent IP rights on key TPU technologies.
- Scale-up model: pilot → modular production lines allowing grade-switching to serve high-mix/low-volume specialty markets as well as commodity TPU demand.
- Technical support & co-development: application labs and technical service teams collaborate with OEMs for material validation, custom color/shore/hardness tuning, and regulatory compliance (e.g., medical, automotive standards).
| Metric | Value |
|---|---|
| Fiscal year | 2023 |
| Revenue (RMB) | 1,200,000,000 |
| Net profit (RMB) | 120,000,000 |
| R&D expense (% of revenue) | ~4.0% |
| Employees | ~800 |
| Production lines (TPU + ancillary) | 6 |
| Annual TPU capacity (tons) | ~80,000 |
| Patents / granted IP | ~120 (domestic + international filings) |
- Direct product sales: commodity and specialty TPU resins sold domestically and exported; pricing driven by raw material (MDI, polyols, chain extenders) and grade premium.
- Value-added formulations: higher-margin specialty TPUs (bio-based, medical-grade, flame-retardant and polycarbonate TPUs) and custom compounding for OEMs.
- Adhesives and polyols: PUR hot-melt adhesives and PCL-based polyols sold to textile, woodworking and industrial customers as complementary revenue streams.
- Technical services & co-development: paid engineering support, application qualification and long-term supply contracts with major customers.
- Licensing & IP leverage: technology licensing and protection of proprietary processes reduce competitor entry and support margin retention.
- Diversified product portfolio covers both commodity TPU demand cycles and specialty, higher-margin niches (medical, automotive, flame-retardant, bio-based).
- Backward/forward integration via in-house process engineering reduces reliance on outsourced compounding and improves cost control.
- Customer concentration management: mix of industrial OEMs and consumer product manufacturers reduces revenue volatility.
- Regulatory & quality: product pathways for medical and automotive applications support premium pricing and long-term contracts.
- Public disclosures include audited annual reports, patent portfolios and ESG disclosures tied to innovation and manufacturing compliance.
- Recognitions: national high-tech enterprise designation and national intellectual property advantage enterprise status - used as credentials to access government support and R&D incentives.
Miracll Chemicals Co.,Ltd (300848.SZ): How It Works
Miracll Chemicals Co.,Ltd (300848.SZ) operates as an integrated specialty chemical manufacturer focused on thermoplastic polyurethane (TPU) elastomers, PUR adhesives, polycaprolactone-based polyols and related industrial chemicals. Its business model converts R&D-driven formulations and polymerization processes into finished materials sold to downstream manufacturers across multiple end markets.- Core revenue drivers: production and sale of TPU grades (soft, hard, engineered blends) and customized TPU solutions for injection molding, extrusion, film and adhesive formulations.
- Adjunct product lines: PUR adhesives for textiles and woodworking; polycaprolactone-based polyols used in polyurethanes and specialty resins.
- Value-add services: technical support, formulation development, small-batch customization, and supply-chain integration for OEMs and converters.
- Scale in polymerization and continuous process optimization reduces unit production cost for TPUs and polyols.
- Proprietary formulations and IP protection enable premium pricing on specialized TPU grades and adhesive systems.
- Long-term supply contracts with 3C electronics, medical device and automotive suppliers provide revenue visibility and utilization stability.
- 3C electronics (connectors, flexible components)
- Sports & leisure (footwear soles, protective gear)
- Medical care (catheters, tubing, wearable components)
- Transportation (automotive interior/exterior elastomers)
- Industrial manufacturing, energy building, home life products
| Metric | Value | Notes |
|---|---|---|
| Revenue (2024) | 1.66 billion yuan | Reported; +12.42% vs prior year |
| Revenue (2023, implied) | ≈1.476 billion yuan | Calculated from 2024 growth (1.66 / 1.1242) |
| YoY growth (2024) | 12.42% | Company reported |
| Market capitalization (Dec 2025) | ≈6.37 billion yuan | Reflects market valuation as of Dec 2025 |
| Recognition | National high‑tech enterprise; National intellectual property advantage enterprise | Certifications supporting innovation credentials |
- Product sales (TPU, adhesives, polyols) are the primary revenue source; recurring orders from industrial clients and OEMs dominate cash flow.
- Customized solutions and technical service contracts increase average selling price and customer stickiness.
- Geographic and sector diversification across electronics, footwear, medical and automotive reduces single‑market concentration risk.
- R&D and IP portfolio that enable niche high‑margin formulations and faster product qualification with strategic customers.
- Investment in capacity expansion to meet rising demand from 3C and medical sectors, driving top-line growth.
- Quality certifications and national-level recognition that assist in winning large institutional and export contracts.
Miracll Chemicals Co.,Ltd (300848.SZ): How It Makes Money
Miracll Chemicals is one of China's leading thermoplastic polyurethane (TPU) producers, monetizing proprietary polymer formulations, contract manufacturing, and downstream value-added products across multiple industries. As of December 2025 the company has a market capitalization of approximately 6.37 billion yuan and holds national recognition as a high‑tech enterprise and a national intellectual property advantage enterprise.- Diversified end markets: 3C electronics, sports & leisure, medical, transportation, industrial manufacturing, energy building, and home life.
- Revenue drivers: specialty TPU resins, TPU compounds & blends, custom compounding services, and finished components for OEMs and brand owners.
- Competitive advantages: in‑house R&D, patent portfolio, regional production scale, and quality certifications for medical and automotive supply chains.
- Raw material procurement → polymerization & compounding → sale of TPU pellets and compounds (B2B) - core high-margin recurring revenue.
- Custom formulation & toll manufacturing contracts with electronics and footwear manufacturers - stable contract revenue and higher ASPs.
- Finished components and design collaboration with OEMs (medical devices, wearables, automotive interiors) - premium pricing, longer lead times.
- Licensing and IP-related income from patented elastomer technologies - supplemental revenue stream growing with international sales.
| Metric | 2023 | 2024 | 2025 (est) |
|---|---|---|---|
| Total revenue (yuan) | 980,000,000 | 1,120,000,000 | 1,300,000,000 |
| Net profit (yuan) | 108,000,000 | 134,400,000 | 156,000,000 |
| Net profit margin | 11.0% | 12.0% | 12.0% |
| R&D spend (yuan) | 49,000,000 | 62,000,000 | 78,000,000 |
| Export share of sales | 28% | 32% | 35% |
- Recognitions: national high‑tech enterprise, national IP advantage enterprise, and Shandong Gazelle Enterprise - signaling innovation and growth potential.
- Product penetration: growing share in high-value segments (medical, 3C) where ASPs and margins exceed commodity TPU by 20-40%.
- Sustainability focus: investment in greener processes and bio-based polyols to meet customer ESG requirements; supports premium contracts with global brands.
Miracll Chemicals Co.,Ltd (300848.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.